Skip to main content

About this Research Topic

Manuscript Submission Deadline 21 February 2024

This Research Topic is accepting articles. For authors aiming to contribute, please submit your manuscript today.

Given the success of the previous collection, Bone Cell Differentiation in Health and Disease, and the new advances in the field, we are pleased to announce the launch of Volume II.

Bones have the unique ability to constantly undergo remodeling even after growth and modeling of the skeleton have been ...

Given the success of the previous collection, Bone Cell Differentiation in Health and Disease, and the new advances in the field, we are pleased to announce the launch of Volume II.

Bones have the unique ability to constantly undergo remodeling even after growth and modeling of the skeleton have been completed. These remodeling processes enable this tissue to respond and adapt to changing functional situations. Bone mass is controlled by the coordinated action of osteoblast and osteoclasts, which form and resorb bone, respectively. The actions of these two cell types as well as their differentiation is modulated by osteocytes. Mesenchymal stem cells have the ability to differentiate into one of the three cell types: osteoblasts, chondrocytes, or adipocytes.

It is now clear that hormones and growth factors produced by cells of other tissues are able to modulate bone modeling and remodeling by altering osteoblast, osteoclast, and osteocyte functions. The status of the bone represents the net result of a balance between the activity of osteoclast and osteoblast, which results compromised as a consequence of endocrine disorders. Thus, it is fundamental to identify new pathways and genes involved in osteogenesis. In certain circumstances, other cell types (e.g., smooth muscle cells, cancer cells) also undergo osteoblast-like differentiation to develop pathological calcification. Moreover, disseminated cancer cells also modulate the functions of bone resident osteoblast and osteoclast cells to deteriorate bone health. Similarly, obese adipocytes, high-cholesterol and diabetic situations disturb bone cell functions and bone health.

This article collection aims to discuss the pathways involved in osteogenesis in health and disease including but not limited to:
- Genes and proteins involved in mesenchymal stem cell differentiation;
- Hormones inhibiting or promoting osteogenesis;
- Pathways involved in osteogenesis impairment as a consequence of endocrine disorders;
- Bone cell response to other endocrine cells signals;
- Osteoblast, osteoclast, and osteocyte function in health and disease
- Atypical osteoblast-like differentiation and disease.

Authors are welcome to submit Original Research, Review, Mini Review, Methods, and Perspective articles to provide readers with up-to-date knowledge in the field of osteogenesis.

Keywords: Osteogenesis, endocrine disorders, bone, osteoblast, genes


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic Editors

Loading..

Topic Coordinators

Loading..

Recent Articles

Loading..

Articles

Sort by:

Loading..

Authors

Loading..

total views

total views article views downloads topic views

}
 
Top countries
Top referring sites
Loading..

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.